Related Experiment Video
Updated: Jul 14, 2026
08:27
Single Synapse Indicators of Glutamate Release and Uptake in Acute Brain Slices from Normal and Huntington Mice
Published on: March 11, 2020
Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy
Ida Manna1, Angelo Labate, Antonio Gambardella
1Institute of Neurological Sciences, National Research Council, Piano Lago Mangone - Cosenza, Italy.
Neuroscience Letters
|June 6, 2007
Summary
The serotonin transporter gene (5-HTT) may influence temporal lobe epilepsy (TLE) risk. Specifically, a VNTR polymorphism in the 5-HTT gene
Area of Science:
- Neurogenetics
- Molecular Psychiatry
Background:
- The serotonin transporter gene (5-HTT) has functional polymorphisms previously linked to altered transcription.
- Understanding genetic contributions to neurological disorders like temporal lobe epilepsy (TLE) is crucial.
Purpose of the Study:
- To investigate the association between 5-HTT gene polymorphisms and TLE susceptibility.
- To determine if specific 5-HTT gene variants contribute to the risk of developing TLE.
Main Methods:
- Genotyping of 5-HTT insertion/deletion (5-HTTLPR) and VNTR (5-HTTVNTR) polymorphisms in 276 TLE patients and 309 controls.
- Statistical analysis using UNPHASED to compare genotype, allele, and haplotype frequencies.
- Inclusion of age and gender as covariates in the analysis.
Main Results:
- No significant association was found for the 5-HTTLPR polymorphism.
- A significant association was observed for the 5-HTTVNTR polymorphism (P=0.0145 for genotypes, P=0.0086 for alleles).
- Patients with TLE exhibited lower frequencies of the 10-repeat allele at 5-HTTVNTR compared to controls.
Conclusions:
- The 5-HTTVNTR polymorphism in the serotonin transporter gene is associated with TLE susceptibility.
- These findings suggest a potential role for the serotonin transporter gene in the etiology of temporal lobe epilepsy.
- Further research is warranted to elucidate the precise mechanisms linking 5-HTT to TLE.
Related Concept Videos
01:21Huntington Disease l: Introduction
Huntington disease or HD is a progressive, fatal neurodegenerative disorder inherited in an autosomal dominant pattern.PathophysiologyIt is caused by expansion of the CAG trinucleotide repeat in the HTT gene on chromosome 4 (4p16.3), producing an abnormal huntingtin protein with an expanded polyglutamine tract. This misfolded protein disrupts cellular function, leading to neuronal death. Normal alleles have ≤26 repeats, 27–35 are intermediate (risk of expansion), 36–39 show reduced penetrance,...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...